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CONDENSATION OF THE RESEARCH 
To explore synthetic polymers as an alternative to antibodies in dru g assays 
Organic monomers were polymerized in the presence of a ligand . The result-
ing polymer stores the ligand shape after the ligand is removed by solvent ex-
traction . Radiolabelled ligand binding assays using this imprinted polymer 
were compared in performance to standard immunoassays. 
Polymers were prepared using methacrylic acid as the functional monomer and 
ethylene glycol dimethacrylate for cross-linking. Theophylline (a broncho-
dilatator) or diazepam (a tranquilizer) were used for imprinting during poly-
merization . Scatchard plot analysis of binding data revealed multiple disso-
c iation constants , suggesting a heterogenous population of binding sites . 
Cross-reactivity to major metabolites was found for 3-methylxanthine in the 
theophylline polymer and for several benzodiazepine derivatives in the diaze-
pam primed polymer but in percentages not higher than known for typical 
antibodies. 
The inhibition of radiolabeled eH) ligand binding to the polymer is inversely 
related to the concentration of drug present in the sample. This principle was 
utilized for a new drug assay. Measurements of known standard drug dilutions 
were reliable (variation coefficient < 6.5%) and in good and linear agreement 
to the results of enzyme-multiplied immunoassays as a control (correlation 
coefficient of 0.98). 
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COMMENTARY ON THE RESEARCH 
Mosbach's group started to investigate the idea of molecular imprinting more 
than 10 years ago. 1 However, even in 1985 the method could only be applied for 
the separation of racemic mixtures (e. g., D-phenylalanine and L-phenylalanine 
ester, separation factor a = 1.3 in acetonitrile).2 One interesting application 
involved the resolution of racemic drugs like /3-blockers. 3 Similar results were 
obtained by other groups. 4.5 
In the present work the principle of molecular imprinting has been put to work 
ingeniously as a measuring tool in a competitive binding assay. Not only is the 
shape of the ligand preserved in the polymer, but it is actually turned into a 
highly specific measuring device. Apart from some cross-reactivity, the spec-
ificity obtained is sufficient to distinguish between very similar drugs; for in-
stance, xanthine and theophylline (l,3-dimethylxanthine). Furthermore, the 
concentration range of sensitivity is comparable to that of antibodies. 
The new technique obviously offers a chemical alternative to antibodies. The 
higher stability of polymers is a potential advantage for this method, in partic-
ular if they are used for repeated measurements such as·in clinical laboratory 
assays or in process control. A drawback is the requirement of suitable interac-
tion points in the imprinting ligand. So far the imprints have only been suc-
cessful for small molecules, though studies for proteins and DNA are 
underway. 
A somewhat opposite strategy to molecular imprinting involves molecular 
container compounds where the incarcerand is actively chosen by the chemist 
to provide a suitable cavity for the guest molecule. 6 In this technique the guest 
molecule can only be protected against a hostile environment; for example, a 
drug can be placed in a hydrophobic cavity to pass body barriers. Nonetheless, 
release at a place of desired action remains a formidable task. Furthermore, 
quantitative measurements are not possible. 
Even more significant than measurement applications is the discovery of an 
independent and completely new mode to recreate a recognition environment 
for ligands. The method is fast and cheap, and the imprinted polymers are 
sufficiently stable to be reused. The elimination of the use of antibody produc-
ing laboratory animals is attractive. A direct and exciting use could well in-
volve studies of the interaction of drugs with artificial receptors created by 
molecular imprinting. The results from such facile experiments are likely to 
yield a better understanding of the specificity of actual molecular recognition 
phenomena. Current hypotheses and models can be tested quickly. The utility 
should be especially poignant when three-dimensional receptor structures are 
hard to come by. 
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